15 Navigating CMC and Nonclinical Challenges with Novel Cell and Gene Therapy Products

Bringing novel cell and gene therapy products to market can be challenging for both nonclinical and CMC. David Pepperl, Diana Colleluori, and Robert Kutner return to talk with James C Taylor about it!